Clinical guides for working dietitians.

What a dietitian actually does for a patient on semaglutide or tirzepatide, the clinical jobs, the lean-mass conversation, scope edges, and when to refer. The case you can make to prescribers.

The Wegovy, Ozempic and Rybelsus dose schedules, when a dose is held or stepped back, managing nausea, and how to map nutrition counselling to each step of the curve.

A meaningful share of GLP-1 weight loss can be muscle, not fat. The three dietetic levers, protein floor, distribution, resistance training, and how to monitor that it's working.

Nausea, constipation, reflux and early fullness, the symptoms that derail treatment. The specific nutrition lever for each, plus the red flags that need a prescriber.

The Mounjaro and Zepbound dose schedule, missed-dose handling, switching with semaglutide, and the nutrition framework that carries across both drugs.

The menopause transition is when women lose bone fastest. The calcium, vitamin D, protein and loading levers that protect it, the evidence, and the honest line on phytoestrogens.

Muscle and bone are lost together in midlife. The protein target, the per-meal distribution that matters, the resolved protein-bone paradox, and weight-inclusive framing.

Iodine sufficiency not maximisation, selenium graded honestly, the levothyroxine timing interactions patients get wrong, and why we never say avoid vegetables.

Why there is no single diabetes diet, carbohydrate amount before quality, the plate method a patient can use tonight, the 15-15 hypo rule, and what time-in-range on a CGM tells you.